Samsung Venture Investment Corporation
Samsung Venture Investment Corporation is the corporate venture arm of Samsung Electronics, founded in 1999 and based in Seoul. It maintains a global presence with activity in innovation hubs such as the San Francisco Bay Area, Boston, London, Tel Aviv, Bangalore, Tokyo, and Beijing, and it backs emerging technology startups across Europe, Asia, and North America. The firm sources and invests in technology companies at multiple stages, from early-stage to pre-IPO, focusing on areas including semiconductors, materials, mobile services, internet, software, security, and enterprise solutions, as well as bioengineering and medical tech. Its investment approach targets companies developing AI, robotics, augmented and virtual reality, cybersecurity, 5G, next generation displays, battery technology, digital health, and insurtech, among others, to support shaping future technologies.
Top Regions
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Boston, MA
Nanoramic Laboratories
Venture Round in 2024
Founded in 2008, Nanoramic Laboratories specializes in developing and manufacturing advanced energy storage solutions. The company designs, manufactures, and licenses Neocarbonix electrodes for rechargeable Li-ion batteries, FastCAP ultracapacitors, and Thermexit thermal interface gap filler pads. Its products are designed to operate under extreme conditions, with applications in electric vehicles, consumer electronics, and industrial sectors.
BrickBio
Venture Round in 2024
BrickBio, Inc. is a biotechnology company focused on the custom tailoring of proteins through site-specific and site-selective modifications for both research and therapeutic purposes. Founded in 2019 and based in Boston, Massachusetts, BrickBio has developed a proprietary bioconjugation platform that utilizes an engineered tRNA synthetase/tRNA pair to enable the modification of proteins derived from eukaryotic and bacterial cell lines. This innovative platform allows for the incorporation of unnatural amino acids, which can be coupled with other molecules for labeling or therapeutic applications, such as the creation of antibody-drug conjugates. By optimizing the selective modification of distinct sites on proteins, BrickBio aims to enhance the characteristics of therapeutics, ultimately improving treatment outcomes for patients.
dacadoo AG
Series A in 2015
Dacadoo AG is a Swiss-based technology company that develops a digital health engagement platform. The platform uses behavioral science, artificial intelligence, and gamification to motivate users to adopt healthier habits and to quantify health risk through a real‑time Health Score. It offers a mobile‑first solution that can be branded or integrated via API, and includes a geolocation walking app. The company serves health insurers, wellness providers, and employers worldwide, providing tools to measure the impact of wellness programs and to improve customer engagement and retention.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.